25 related articles for article (PubMed ID: 8952562)
1. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy.
Dimopoulos JC; Petrow P; Tanderup K; Petric P; Berger D; Kirisits C; Pedersen EM; van Limbergen E; Haie-Meder C; Pötter R
Radiother Oncol; 2012 Apr; 103(1):113-22. PubMed ID: 22296748
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension.
deSouza NM; Dina R; McIndoe GA; Soutter WP
Gynecol Oncol; 2006 Jul; 102(1):80-5. PubMed ID: 16427688
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
Tacev T; Vacek A; Ptácková B; Strnad V
Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
[TBL] [Abstract][Full Text] [Related]
4. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
[TBL] [Abstract][Full Text] [Related]
5. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
Bosković V; Glisić A; Petković S
Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
[TBL] [Abstract][Full Text] [Related]
6. Signal characteristics of tumors shown by high-resolution endorectal coil magnetic resonance imaging may predict outcome among patients with cervical carcinoma treated with irradiation. A preliminary study.
Corn BW; Schnall MD; Milestone B; King S; Hauck W; Solin LJ
Cancer; 1996 Dec; 78(12):2535-42. PubMed ID: 8952562
[TBL] [Abstract][Full Text] [Related]
7. Optimal management of locally advanced cervical carcinoma.
Keys H; Gibbons SK
J Natl Cancer Inst Monogr; 1996; (21):89-92. PubMed ID: 9023835
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
9. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging in cervical carcinoma: diagnosis, staging, and follow-up.
Ebner F; Tamussino K; Kressel HY
Magn Reson Q; 1994 Mar; 10(1):22-42. PubMed ID: 8161484
[TBL] [Abstract][Full Text] [Related]
11. Predicting the response of advanced cervical and ovarian tumors to therapy.
Harry VN; Gilbert FJ; Parkin DE
Obstet Gynecol Surv; 2009 Aug; 64(8):548-60. PubMed ID: 19624866
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
